Dynamic MRI of a hypovascularized liver tumor model: Comparison of a new blood pool contrast agent (24-gadolinium-DTPA-cascade-polymer) with gadopentetate dimeglumine

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 4, 1997, Pages 678-682

  Tacke, Josef ^a   Adam, Gerhard ^a   Claßen, Holger ^a   Mühler, Andreas ^b   Prescher, Andreas ^a   Günther, Rolf W ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

24 Gadolinium DTPA cascade polymer; Blood pool contrast agent; Experimental liver tumor; Gadopentetate dimeglumine; MRI; VX 2 carcinoma

Indexed keywords

GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE;

ANIMAL EXPERIMENT; ARTICLE; CONTRAST ENHANCEMENT; FEMALE; LIVER BLOOD FLOW; LIVER TUMOR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBITS AND HARES; RAT; TUMOR BLOOD FLOW;

ANIMALS; CONTRAST MEDIA; DRUG COMBINATIONS; FEMALE; GADOLINIUM; GADOLINIUM DTPA; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MAGNETIC RESONANCE IMAGING; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; POLYMERS; RABBITS; TIME FACTORS;

EID: 0031404148     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070412     Document Type: Article

References (13)

1. Brasch RC. Rationale and applications for macromolecular Gd-based contrast agents. Magn Reson Med 1991; 22:282-287.
2. Brasch RC. New directions in the development of MR imaging contrast media. Radiology 1992; 183:1-11.
3. Adam G, Neuerburg J, Spüntrup E, Mühler A, Scherer K, Günther RW. Dynamic contrast-enhancement MR imaging of the upper abdomen: enhancement properties of gadubutrol, gadolinium-DTPA-polylysine, and gadolinium-DTPA-cascade-polymer. Magn Reson Med 1994; 32:622-628.
4. Young SW. MR contrast media for hepatic imaging. In: Proceedings of the UCSF Workshop on Clinical MR Imaging. San Francisco: University of California at San Francisco, 1990; 412-414.
5. Edelmann RR, Siegek BJ, Singer A, Dupuis K, Longmaid HE. Dynamic MR imaging of the liver with Gd-DTPA: initial clinical results. AJR Am J Roentgenol 1989; 153:1213-1219.
6. Van Hecke P, Marchal G, Bosmans H, et al. NMR imaging study of the pharmacodynamics of polylysine-gadolinium-DTPA in the rabbit and the rat. Magn Reson Imaging 1991;9:313-321.
7. Bucher O. Cytologie und histologie und mikroskopische anatomie des menschen. Bern: Huber Verlag; 1977;234.
8. Gerlowsky LE, Jain RK. Microvascular permeability of normal and neoplastic tissues. Microvasc Res 1986; 3:288-305.
9. Wikström MG, Moseley ME, White DL, et al. Contrast-enhanced MRI of tumors: comparison of Gd-DTPA and a macromolecular agent. Invest Radiol 1989; 24:609-615.
10. Brasch RC, Weinmann HJ, Wesbey GE. Contrast enhanced NMR imaging: animal studies using gadolinium-DTPA complex. AJR Am J Roentgenol 1984; 142:625-630.
11. Schmiedl U, Ogan M, Paajanen H, et al. Albumin labeled with Gd-DTPA as an intravascular, blood-pool enhancing agent for MR imaging: biodistribution and imaging studies. Radiology 1987; 162:205-310.
12. Schmiedl U, Moseley ME, Sievers R, et al. Magnetic resonance imaging of myocardial infarction using albumin-(Gd-DTPA), a macromolecular blood-volume contrast agent in a rat model. Invest Radiol 1987; 22:713-721.
13. Wang SC, Wikström MG, White DL, et al. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: Imaging characteristics in normal rat tissues. Radiology 1990; 175:483-488.